Cuál es el precio por Anteris Technologies Global Corp. (AVR)

Precio por Anteris Technologies Global Corp. (AVR) es de$8.88

Cuál es la capitalización de mercado por Anteris Technologies Global Corp. (AVR)

Capitalización de mercado por Anteris Technologies Global Corp. (AVR) es $863.29M

Anteris Technologies Global Corp. (AVR) Historial de Precios

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Año	Rendimiento
2026 (TTM)	28.26%
2025	-11.64%
2024	0.00%

Año

Rendimiento

2026 (TTM)

28.26%

2025

-11.64%

2024

0.00%

Empresa	Precio de la acción	Cambio 1a%	País
Abbott Laboratories ABT.US	$112.64	-15.09%	US
Stryker Corporation SYK.US	$331.44	-15.32%	US
Medtronic plc MDT.US	$91.30	-1.63%	IE
Boston Scientific Corporation BSX.US	$46.83	-55.61%	US
Siemens Healthineers AG SHL.DE	$46.88	-15.20%	DE

Empresa

Precio de la acción

Cambio 1a%

País